Outcomes of SARS-Cov-2 infection after COVID-19 vaccination in 1730 hospital admitted cases – An observational study from a tertiary care indian hospital

Background and Aims: This study aimed to ascertain a number of SARS-CoV-2 infections in patients who had received either dose of vaccination, admitted in a tertiary care center, in New Delhi, and make a comparison with morbidity and mortality. Methods: Data were collected from COVID-19 patients admi...

Full description

Saved in:
Bibliographic Details
Main Authors: Amit Roy, Gargi Dey
Format: Article
Language:English
Published: SAGE Publishing 2022-01-01
Series:Apollo Medicine
Subjects:
Online Access:http://www.apollomedicine.org/article.asp?issn=0976-0016;year=2022;volume=19;issue=1;spage=7;epage=11;aulast=Roy
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849469150880071680
author Amit Roy
Gargi Dey
author_facet Amit Roy
Gargi Dey
author_sort Amit Roy
collection DOAJ
description Background and Aims: This study aimed to ascertain a number of SARS-CoV-2 infections in patients who had received either dose of vaccination, admitted in a tertiary care center, in New Delhi, and make a comparison with morbidity and mortality. Methods: Data were collected from COVID-19 patients admitted from April 1, 2021, to May 31, 2021. It included the type of vaccination (ChAdOx1 nCoV-19 or BBV152) and the number of doses taken. Mortality and morbidity data were collected and compared based on the computed tomography (CT) severity score. Results: Among 1730 patients, 477 (27.5%) were vaccinated, of which 389 received ChAdOx1 nCoV-19 and 63 received BBV152 vaccine. In 46 patients with breakthrough infection, 7 succumbed. Observed mortality rate was 11.4% (197), of which 53 received a single dose, 11 were completely vaccinated, and 144 were unvaccinated. Among patients who took only one dose, CT severity was mild in 24, moderate in 131, and severe in 27 cases. In fully vaccinated, it was mild in 7, moderate in 22, and severe in just 1 case. Among unvaccinated, 53 had a mild, 349 moderate, and 67 a severe score. Comorbidities were noted in 103 expired patients. Conclusions: The study shows that <30% of patients were vaccinated. Only a handful had completed both doses. Reassuringly, only one among the fully vaccinated had a severe CT score. Although comorbidity influences the prognosis, most of the completely vaccinated who succumbed had no comorbidity. Hence, more research and larger data need to be gathered regarding postvaccination COVID-19 infection.
format Article
id doaj-art-f7e08f59699e43178a5eff0f2d3beb67
institution Kabale University
issn 0976-0016
2213-3682
language English
publishDate 2022-01-01
publisher SAGE Publishing
record_format Article
series Apollo Medicine
spelling doaj-art-f7e08f59699e43178a5eff0f2d3beb672025-08-20T03:25:37ZengSAGE PublishingApollo Medicine0976-00162213-36822022-01-0119171110.4103/am.am_121_21Outcomes of SARS-Cov-2 infection after COVID-19 vaccination in 1730 hospital admitted cases – An observational study from a tertiary care indian hospitalAmit RoyGargi DeyBackground and Aims: This study aimed to ascertain a number of SARS-CoV-2 infections in patients who had received either dose of vaccination, admitted in a tertiary care center, in New Delhi, and make a comparison with morbidity and mortality. Methods: Data were collected from COVID-19 patients admitted from April 1, 2021, to May 31, 2021. It included the type of vaccination (ChAdOx1 nCoV-19 or BBV152) and the number of doses taken. Mortality and morbidity data were collected and compared based on the computed tomography (CT) severity score. Results: Among 1730 patients, 477 (27.5%) were vaccinated, of which 389 received ChAdOx1 nCoV-19 and 63 received BBV152 vaccine. In 46 patients with breakthrough infection, 7 succumbed. Observed mortality rate was 11.4% (197), of which 53 received a single dose, 11 were completely vaccinated, and 144 were unvaccinated. Among patients who took only one dose, CT severity was mild in 24, moderate in 131, and severe in 27 cases. In fully vaccinated, it was mild in 7, moderate in 22, and severe in just 1 case. Among unvaccinated, 53 had a mild, 349 moderate, and 67 a severe score. Comorbidities were noted in 103 expired patients. Conclusions: The study shows that <30% of patients were vaccinated. Only a handful had completed both doses. Reassuringly, only one among the fully vaccinated had a severe CT score. Although comorbidity influences the prognosis, most of the completely vaccinated who succumbed had no comorbidity. Hence, more research and larger data need to be gathered regarding postvaccination COVID-19 infection.http://www.apollomedicine.org/article.asp?issn=0976-0016;year=2022;volume=19;issue=1;spage=7;epage=11;aulast=Roybbv152 vaccinechadox1 ncov-19 recombinant coronavirus vaccinecomorbiditiescomputed tomography severity scorecovid-19morbiditymortalitysars-cov-2vaccination
spellingShingle Amit Roy
Gargi Dey
Outcomes of SARS-Cov-2 infection after COVID-19 vaccination in 1730 hospital admitted cases – An observational study from a tertiary care indian hospital
Apollo Medicine
bbv152 vaccine
chadox1 ncov-19 recombinant coronavirus vaccine
comorbidities
computed tomography severity score
covid-19
morbidity
mortality
sars-cov-2
vaccination
title Outcomes of SARS-Cov-2 infection after COVID-19 vaccination in 1730 hospital admitted cases – An observational study from a tertiary care indian hospital
title_full Outcomes of SARS-Cov-2 infection after COVID-19 vaccination in 1730 hospital admitted cases – An observational study from a tertiary care indian hospital
title_fullStr Outcomes of SARS-Cov-2 infection after COVID-19 vaccination in 1730 hospital admitted cases – An observational study from a tertiary care indian hospital
title_full_unstemmed Outcomes of SARS-Cov-2 infection after COVID-19 vaccination in 1730 hospital admitted cases – An observational study from a tertiary care indian hospital
title_short Outcomes of SARS-Cov-2 infection after COVID-19 vaccination in 1730 hospital admitted cases – An observational study from a tertiary care indian hospital
title_sort outcomes of sars cov 2 infection after covid 19 vaccination in 1730 hospital admitted cases an observational study from a tertiary care indian hospital
topic bbv152 vaccine
chadox1 ncov-19 recombinant coronavirus vaccine
comorbidities
computed tomography severity score
covid-19
morbidity
mortality
sars-cov-2
vaccination
url http://www.apollomedicine.org/article.asp?issn=0976-0016;year=2022;volume=19;issue=1;spage=7;epage=11;aulast=Roy
work_keys_str_mv AT amitroy outcomesofsarscov2infectionaftercovid19vaccinationin1730hospitaladmittedcasesanobservationalstudyfromatertiarycareindianhospital
AT gargidey outcomesofsarscov2infectionaftercovid19vaccinationin1730hospitaladmittedcasesanobservationalstudyfromatertiarycareindianhospital